Table 1.
Entry | € |
---|---|
Voretigene-Neparvovec per eye | 410,550 |
Pharmacy per eye | 2000 |
DRG G18Z reimbursement per eye | 2840 |
Outpatient reimbursement per quarter | 220 |
Direct costs year 1 | 831,660 |
Direct costs year n | 220 |
Direct costs per year are added for the treatment of both eyes. DRG, diagnosis related group.